Provider Impact

Healthcare Growth Strategies for Providers & Pharmacies

Home
Categories
Featured Business Profiles

September 14.2026

2 Minutes Read

Why Hospital Consolidation Needs a Patient-Centric Focus

Concept illustration of a hospital administrator and physician listening to a patient representative

Understanding the Impact of Hospital Consolidation

The debate surrounding hospital consolidation often revolves around financial considerations, yet recent insights suggest that the patient experience and overall healthcare quality are significantly affected as well. As more hospitals merge, executives must prioritize not just the economic benefits but also how these changes impact patient care and access. This discussion is critical for hospital executives, healthcare administrators, and provider leaders who steer the future of healthcare delivery.

Why Patient Perspectives Matter

Mainly, the patient experience is often overlooked in consolidation discussions. When hospitals merge, there can be a shift in the focus of care from patient needs to organizational efficiency. A recent report highlights that patients may face longer wait times and reduced quality of care when healthcare systems consolidate. Therefore, it is essential for industry leaders to remain closely aligned with patient perspectives in their decisions.

A Broader Lens: Balancing Economics and Care

While cost savings from consolidations can lead to improved financial health for organizations, it’s vital to balance these benefits with the impacts on quality of care. Evidence suggests that where consolidation occurs, hospitals may prioritize certain clinical specializations over others, leading to disparities in care access. Healthcare professionals must consider how economic decisions reverberate across all levels of patient experience.

Looking to the Future: A Call for Mindful Consolidation

The future landscape of healthcare hinges on a balanced approach to consolidation. Healthcare administrators should adopt a model that not only focuses on the bottom line but prioritizes patient health outcomes as well. By embracing a patient-centered care model during consolidation discussions, organizations can foster environments that enhance the healthcare experience rather than detract from it.

Provider Spotlights

3 Views

0 Comments

Write A Comment

Please complete the captcha to submit your comment.

Related Posts All Posts

09.14.2026

New Study Questions Survival Benefits of ADC in NSCLC Treatment

Update New Insights on Metastatic NSCLC Treatment Outcomes The latest research presented at the World Conference on Lung Cancer (WCLC) unveils significant findings regarding the treatment of metastatic non-small cell lung cancer (NSCLC). Despite the anticipation, the combination of sacituzumab govitecan and pembrolizumab did not yield the expected survival improvements, raising questions about the future of such combinations in clinical practice. These results highlight the complexities faced in targeting one of the most common types of lung cancer, which remains a leading cause of cancer-related deaths globally. PFS Results: A Closer Look The EVOKE-03 trial highlighted a slight enhancement in median progression-free survival (PFS)—from 7.7 months with pembrolizumab alone to 11.8 months combined with sacituzumab. However, as Dr. Giannis Mountzios from Henry Dunant Hospital Center pointed out, this difference failed to achieve statistical significance. This lack of significant improvement prompts reflection on the effectiveness of adding this antibody-drug conjugate (ADC) to existing immunotherapy treatments. The idea of merging innovative therapies for better patient outcomes is appealing, but the data suggests that such efforts must be backed by robust statistical evidence. Overall Survival: Questions Persist An interim analysis revealed an unexpected trend—overall survival (OS) was reportedly better in the control group, with a median survival of 22.8 months versus 21.5 months for the combination therapy. It’s important to recognize that these results came from a highly selective patient group, specifically chosen for PD-L1 positivity. This specific focus raises the question of generalizability across broader patient populations, a key consideration as clinicians aim to find the most effective treatment protocols. Even so, Dr. Mountzios noted that prespecified analyses hinted at a potential benefit in East Asian and Chinese populations, though these findings likewise did not reach statistical significance. This points toward the need for culturally and geographically tailored research as we expand our understanding of treatment options. Safety Profiles and Treatment Considerations The trial also observed a concerning trend in treatment-emergent adverse events. Patients receiving the combined therapy experienced more serious adverse events (AEs), including treatment discontinuations and fatalities, compared to those on pembrolizumab alone. This raises valid concerns about the risk-benefit balance when considering combinations of therapies, especially for vulnerable patient populations. Understanding the full spectrum of potential side effects can aid medical professionals in providing comprehensive care, ensuring that they can discuss risks candidly with their patients, especially those who might be weighing the impact of treatment on their quality of life. Reflections on Previous Trials and Expectations The historical context surrounding these trials cannot be ignored. Pembrolizumab established a formidable benchmark during the KEYNOTE-024 trial, boasting an impressive objective response rate (ORR) of 44.8%. This high bar has shaped expectations in the oncology field, particularly as newer therapies are introduced. Comparatively, the EVOKE-02 trial had indicated high ORR rates with sacituzumab, leading to optimism that did not translate into this latest phase III trial. Dr. Ji-Youn Han emphasized the importance of realistic expectations based on historical performance metrics. The stark contrast in results underlies the intricate nature of cancer biology and the need for caution when interpreting early positive findings from smaller trials. Future Directions: What Lies Ahead? As the landscape of NSCLC treatment continues to evolve, the results from EVOKE-03 underscore a need for more focused future trials. Specifically, Dr. Han called for future studies to prioritize overall survival as the primary endpoint, ensuring appropriate biomarker selection alongside stratified populations by histology and geography. This meticulous approach could illuminate clearer pathways for improving patient outcomes in NSCLC. The emphasis on well-defined endpoints aligns with a broader move within oncology research to focus on tangible results that directly impact patient health and well-being. Key Takeaways for Healthcare Professionals For physicians, nurse practitioners, and healthcare providers, understanding these recent findings is crucial for informed decision-making in clinical practice. As the landscape of lung cancer treatment continues to be redefined by ongoing research updates and clinical trials, leveraging this information can foster better patient-centered care and optimize outcomes. Clinicians must balance the hope associated with new therapies against the reality of trial results, ensuring that treatment plans are both innovative and evidence-based. Engaging in discussions about the implications of these findings can also empower patients, making them active participants in their healthcare journey. Conclusion: A Call for Cautious Optimism While the addition of sacituzumab to pembrolizumab didn’t yield the anticipated enhancements in survival rates, it does not diminish the value of clinical research in aggregate. The cycle of trial and error, coupled with continuous learning from each study, remains essential in the quest for effective cancer therapies. As new data emerges, healthcare providers must remain adaptable and committed to refining treatment strategies tailored to individual patient needs. The ongoing commitment to patient care, rooted in evidence-based practices, will ultimately guide the oncology community towards better therapeutic strategies and improved patient outcomes.

09.12.2026

How a $100 Million Initiative Aims to Transform U.S. Maternal Care

Update Rethinking Maternal Health: A $100 Million Commitment to Change In a groundbreaking initiative, the bipartisan campaign Healthy Moms, Healthy Babies America, spearheaded by philanthropists Olivia and Tom Walton, has announced a staggering $100 million commitment aimed at dramatically reducing the alarming maternal mortality rate in the United States. This ambitious five-year plan is designed to cut maternal deaths in half by 2031, a goal deemed ‘eminently solvable’ by health leaders. This commitment reflects a growing awareness and urgency surrounding maternal health issues, which have long been neglected in discussions about healthcare reform. The Current State of Maternal Mortality Despite being one of the wealthiest nations, the U.S. grapples with one of the highest maternal mortality rates among developed countries. Recent statistics revealed that in 2024 alone, 688 women died during pregnancy or shortly after giving birth, resulting in a rate of 19 deaths per 100,000 live births. This figure reflects an increase from 18.6 in the previous year, underscoring an urgent need for systemic change in maternal healthcare. To put this in perspective, the maternal mortality rate in many comparable countries is significantly lower, demonstrating a troubling trend that merits immediate attention and action. Understanding the Causes Behind the Crisis According to Dr. Neel Shah, president of Healthy Moms, Healthy Babies America, the problem is not merely a lack of knowledge; it’s the underexecution of known solutions that poses the biggest challenge. This initiative aims to address this gap by enhancing data collection and hospital reporting, which are foundational for understanding and addressing maternal health outcomes. Accurate data can point out disparities in care, identify high-risk populations, and ultimately lead to more tailored and effective interventions. Strategies for Change: Learning from Success Stories California and New Jersey serve as shining examples of how strategic interventions can lead to substantial improvements in maternal health outcomes. California has cut its maternal mortality rate by half through targeted investments and effective strategies, adopting a multifaceted approach by integrating healthcare services and focusing on community engagement. New Jersey, previously ranked 47th in maternal mortality, has seen marked improvements by focusing resources and care in the cities with the greatest needs, illustrating how tailored policies can have a real impact. “States are in the driver’s seat for these changes,” says Walton. With about 40% of births funded through Medicaid, state-focused solutions have the potential to drive real progress. The campaign will not only rely on philanthropic investments but also catalyze state and federal supports through proposed legislation addressing rural obstetric care access. These legislative efforts are crucial, as they can provide necessary funding and policy backing for states, enabling them to implement successful interventions seen in other areas. The Role of Federal and State Governments Health leaders, including Senator Katie Britt (R-Ala.), emphasize the need for collective action across both public and private sectors to reverse this troubling trend. Having bipartisan support for bills such as the Rural Obstetrics Readiness Act can expand access to vital maternal care—particularly in underserved areas. Senator Britt reiterated that maternal health is a nonpartisan issue, stating that ensuring safe pregnancies should be a universal goal, transcending political lines and divisions. A Call to Action: Building a Collective Will With the $100 million investment as a launchpad, Healthy Moms, Healthy Babies America aims to encourage state governments to match this commitment and amplify the impact through local initiatives. Walton envisions this approach not only proving effective but also inspiring further funding from corporations and stakeholders in the healthcare sphere. She emphasized that taking calculated risks with philanthropic efforts may galvanize additional interest from the private sector to support sustainable changes in maternal health. Empowering Healthcare Providers and Communities This initiative will also focus on training midwives and expanding postpartum care services, especially in rural and underserved communities. By doing so, the program addresses one of the critical gaps in current maternal care: the availability of skilled professionals who can provide adequate support during and after pregnancy. These crucial enhancements underscore the initiative's commitment to a more equitable healthcare landscape where every mother has access to the care she needs, regardless of her geographical location or socioeconomic status. Transforming Maternal Healthcare: The Path Forward As healthcare providers and policymakers look ahead, this pivotal moment offers a chance to transform maternal healthcare for the better. By leveraging data and proven strategies, the United States stands on the brink of a significant downward trend in maternal mortality—a change that will save lives and improve the health of mothers and newborns alike. The pledge by Healthy Moms, Healthy Babies America is not simply an investment; it is a call for systemic change in how maternal healthcare is approached across the nation. It’s time for healthcare professionals to engage with this initiative, advocate for policy changes, and implement best practices that align with these new goals. This collaborative effort, combining resources across different sectors, is crucial in addressing the multifaceted issues plaguing maternal health in America. The commitment from Healthy Moms, Healthy Babies America serves as a hopeful signal that change is not only possible but is indeed underway, potentially reshaping the future of maternal health in a nation where every mother deserves to thrive.

09.12.2026

The Cyclospora Outbreak Linked to Iceberg Lettuce: Lessons for Healthcare Leaders

Update Understanding the Cyclospora Outbreak: What Healthcare Leaders Need to Know The cyclone of a cyclospora outbreak has concluded, as recently reported by the Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA). A formal announcement made on September 11 declared the outbreak linked to contaminated iceberg lettuce over, following a marked decline in reported infections. The public can breathe a sigh of relief as the CDC reassures that no residual tainted lettuce remains in stores or restaurants. Impact on the Healthcare System This cyclospora outbreak has been particularly alarming, with approximately 12,883 reported infections and a tragic toll of two deaths across 21 states. The rise in cyclospora cases, often tied to fresh produce, raises concerns for healthcare leaders. Outbreaks like this require efficient communication and swift response mechanisms within the healthcare system, highlighting the necessity for heightened surveillance and preparedness to prevent future occurrences. Continuing Investigations Following the conclusion of this outbreak, the FDA continues to investigate its origins, which have been traced back to iceberg lettuce supplied by Taylor Farms from Mexico. This underscores the importance of food safety and traceability initiatives within healthcare administration. Hospital executives and policy-makers must closely monitor such reports to inform their crisis management and public health policies, creating more robust frameworks to address foodborne illnesses. The Road Ahead: Preventative Measures The declaration of this outbreak's end provides an opportunity for introspection and improvement. Healthcare professionals must emphasize food safety education and foster better practices among producers and distributors. By improving regulatory compliance and holding suppliers accountable, the healthcare community can work towards minimizing risks associated with foodborne pathogens.

Provider Impact

Provider Impact is a news and insights platform for healthcare professionals—covering policy, innovation, and business trends that shape the care industry.

COMPANY

Privacy Policy
Terms of Use
Advertise
Contact Us
Menu 5
Menu 6

(949) 375-3833

AVAILABLE FROM 8AM - 5PM

Huntington Beach, CA
18685 Main Street 101-228
Huntington Beach, CA 92649

ABOUT US

Provider Impact brings together trusted reporting, expert voices, and healthcare industry updates in one dedicated space. Our goal is to keep providers informed and connected to the trends and decisions that impact their work and their patients.

{"company":"High Octane Media","address":"18685 Main Street 101-228","city":"Huntington Beach","state":"CA","zip":"92648","email":"rick@highoctanelocal.com","tos":"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","privacy":"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"}